Part 1. Definition
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Part 2. Example
SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Answer: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.
Part 3. Exercise
SECTION 1. SHORT TITLE.

This Act may be cited as the ''Global Pediatric HIV/AIDS Prevention
and Treatment Act''.

SEC. 2. FINDINGS.

Section 2 of the United States Leadership Against HIV/AIDS,
Tuberculosis, and Malaria Act of 2003 (26 U.S.C. 7601) is amended--
(1) in paragraph (3), by adding at the end the following:
''(D) In 2007, the rate at which children accessed
treatment failed to keep pace with new pediatric infections.
While children account for almost 16 percent of all new HIV
infections, they make up only 9 percent of those receiving
treatment under this Act.'';
(2) by amending paragraph (16) to read as follows:
''(16) Basic interventions to prevent new HIV infections
and to bring care and treatment to people living with AIDS,
such as voluntary counseling and testing, are achieving
meaningful results and are cost-effective. The challenge is to
expand these interventions to a national basis in a coherent
and sustainable manner.''; and
(3) by amending paragraph (20) to read as follows:
''(20) With no medical intervention, mothers infected with
HIV have a 25 to 30 percent chance of passing the virus to
their babies during pregnancy and childbirth. A simple and
effective intervention can significantly reduce mother to child
transmission of HIV. A single dose of an anti-retroviral drug
given once to the mother at the onset of labor, and once to the
baby during the first 3 days of life reduces transmission by
approximately 50 percent. Other more complex drug regimens can
further reduce transmission from mother-to-child. A dramatic
expansion of access to prevention of mother-to-child
transmission services is critical to preventing thousands of
new pediatric HIV infections.''.

SEC. 3. POLICY PLANNING AND COORDINATION.

Section 101(b)(3) of the United States Leadership Against HIV/AIDS,
Tuberculosis, and Malaria Act of 2003 (22 U.S.C. 7611(b)(3)) is amended
by adding at the end the following:
''(X) A description of the activities that will be
conducted to achieve the targets described in
paragraphs (1) and (2) of section 312(b).''.

SEC. 4. BILATERAL EFFORTS.

(a) Assistance To Combat HIV/AIDS.--Section 104A of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b-2) is amended--
(1) in subsection (d)(1)--
(A) by amending subparagraph (E) to read as
follows:
''(E) assistance to--
''(i) achieve the target described in
section 312(b)(1) of the United States
Leadership Against HIV/AIDS, Tuberculosis, and
Malaria Act of 2003; and
''(ii) promote infant feeding options for
HIV positive mothers that are consistent with
the most recent infant feeding recommendations
and guidelines supported by the World Health
Organization;'';
(B) in subparagraph (G), by striking ''and'' at the
end;
(C) in subparagraph (H), by striking the period at
the end and inserting ''; and''; and
(D) by adding at the end the following:
''(I) assistance to achieve the target described in
section 312(b)(2) of the United States Leadership
Against HIV/AIDS, Tuberculosis, and Malaria Act of
2003.''; and
(2) in subsection (e)(2)(C)--
(A) in clause (iii), by striking ''and'' at the
end;
(B) in clause (iv), by striking the period at the
end and inserting ''; and''; and
(C) by adding at the end the following:
''(v) the number of HIV-infected children
currently receiving antiretroviral medications
in each country under the United States
Leadership Against HIV/AIDS, Tuberculosis, and
Malaria Act of 2003.''.
(b) Assistance to Children and Families.--Subtitle B of Title III
of the United States Leadership Against HIV/AIDS, Tuberculosis, and
Malaria Act of 2003 (22 U.S.C. 7651 et seq.) is amended by striking
sections 311 and 312 and inserting the following:

''SEC. 311. FINDINGS.

''Congress makes the following findings:
''(1) Every day, approximately 1,100 children around the
world are infected with HIV, the vast majority through mother-
to-child transmission during pregnancy, labor or delivery or
soon after through breast-feeding. Approximately 90 percent of
these infections occur in Africa.
''(2) With no medical intervention, mothers infected with
HIV have a 25 to 30 percent chance of passing the virus to
their babies during pregnancy and childbirth. A single dose of
an anti-retroviral drug given once to the mother at the onset
of labor, and once to the baby during the first 3 days of life
reduces transmission by approximately 50 percent.
''(3) Providing the full range of interventions, as is the
standard of care in the United States, could reduce the rate of
mother-to-child transmission of HIV to as little as 2 percent.
''(4) Global coverage of services to prevent transmission
from mother-to-child remains unacceptably low. The Joint United
Nations Program on HIV/AIDS (UNAIDS) reports that fewer than 10
percent of pregnant women with HIV in resource-poor countries
have access to prevention of mother-to-child transmission
services.
''(5) Prevention of mother-to-child transmission programs
provide health benefits for women and children beyond
preventing the vertical transmission of HIV. They serve as an
entry point for mothers to access treatment for their own HIV
infection, allowing them to stay healthy and to care for their
children. Efforts to connect and integrate prevention of
mother-to-child transmission and HIV care, treatment and
prevention programs are crucial to achieving improved outcomes
for HIV-affected and HIV-infected women and families.
''(6) Access to comprehensive HIV prevention services must
be drastically scaled-up among pregnant women infected with HIV
and pregnant women not infected with HIV to further protect
themselves and their partners against the sexual transmission
of HIV/AIDS.
''(7) Preventing unintended pregnancy among HIV-infected
women is recognized by the World Health Organization and the
Office of the United States Global AIDS Coordinator to be an
integral component of prevention of mother-to-child
transmission programs. To further reduce infection rates, women
accessing prevention of mother-to-child transmission services
must have access to a range of high-quality family planning and
reproductive health care, so they can make informed decisions
about future pregnancies and contraception.
''(8) In 2007, the rate at which children were accessing
treatment failed to keep pace with new pediatric infections.
While children account for almost 16 percent of all new HIV
infections, they make up only 9 percent of those on treatment
under this Act.
''(9) Of the more than 2,500,000 people who were newly
infected with HIV in 2007, more than 420,000 were children.
''(10) Without proper care and treatment, half of newly
HIV-infected children will die before they reach 2 years of
age, and 75 percent will die before 5 years of age.
''(11) Because children are not just small adults,
providing HIV care and treatment presents special challenges,
including--
''(A) limited access to reliable HIV testing for
the youngest children;
''(B) a shortage of providers trained in delivering
pediatric care;
''(C) weak linkages between services to prevent
mother-to-child transmission and care and treatment
programs; and
''(D) the need for low-cost pediatric formulations
of HIV/AIDS medications.

''SEC. 312. POLICY AND REQUIREMENTS.

''(a) Policy.--
''(1) In general.--The United States Government's response
to the global HIV/AIDS pandemic should place high priority on--
''(A) the prevention of mother-to-child
transmission of HIV/AIDS; and
''(B) the care and treatment of all children
affected by HIV/AIDS, including children orphaned by
AIDS.
''(2) Collaboration.--The United States Government should
work in collaboration with foreign governments, donors, the
private sector, nongovernmental organizations, and other key
stakeholders.
''(b) Requirements.--The comprehensive, 5-year, global strategy
required under section 101 shall--
''(1) establish a target for prevention of mother-to-child
transmission efforts that by 2013, in those countries most
affected by HIV--
''(A) 80 percent of pregnant women receive HIV
counseling and testing; and
''(B) all of the pregnant women receiving HIV
counseling and testing who test positive for HIV
receive anti-retroviral medications for prevention of
mother-to-child transmission of HIV;
''(2) establish a target requiring that by 2013, children
account for at least 15 percent of those receiving treatment
under this Act;
''(3) integrate prevention, care, and treatment with
prevention of mother-to-child transmission programs, as soon as
feasible and consistent with the national government policies
of the foreign countries in which programs under this Act are
administered, to improve outcomes for HIV-affected women and
families and to promote follow-up and continuity of care;
''(4) expand programs designed to care for children
orphaned by AIDS; and
''(5) develop a time line for expanding access to more
effective mother-to-child transmission prevention regimens,
consistent with the national government policies of the foreign
countries in which programs under this Act are administered and
the goal of moving towards universal use of such regimens as
rapidly as possible.
''(c) Application of Requirements.--All strategic planning
documents and bilateral funding agreements developed under the
authority of the Office of the United States Global AIDS Coordinator,
including country operating plans and any subsequent mechanisms through
which funding under this Act is obligated, shall be consistent with,
and in furtherance of, the requirements under subsection (b).
''(d) Prevention of Mother-to-Child Transmission Expert Panel.--
''(1) Establishment.--The Coordinator of United States
Government Activities to Combat HIV/AIDS Globally (referred to
in this section as the 'Coordinator') shall establish a panel
of experts to be known as the Prevention of Mother to Child
Transmission Panel (referred to in this section as the 'Panel')
to--
''(A) provide an objective review of activities to
prevent mother-to-child transmission of HIV that
receive financial assistance under this Act; and
''(B) provide recommendations to the Coordinator
and to the appropriate committees of Congress for
scale-up of mother-to-child transmission prevention
services under this Act in order to achieve the target
established in subsection (b)(1).
''(2) Membership.--The Panel shall be convened and chaired
by the Coordinator, who shall serve as a nonvoting member. The
Panel shall consist of not more than 15 members (excluding the
Coordinator), to be appointed by the Coordinator not later than
60 days after the date of the enactment of this Act,
including--
''(A) 2 members from the Department of Health and
Human Services with expertise relating to the
prevention of mother-to-child transmission activities;
''(B) 2 members from the United States Agency for
International Development with expertise relating to
the prevention of mother-to-child transmission
activities;
''(C) 2 representatives from among health ministers
of national governments of foreign countries in which
programs under this Act are administered;
''(D) 3 members representing organizations
implementing prevention of mother-to-child transmission
activities under this Act;
''(E) 2 health care researchers with expertise
relating to global HIV/AIDS activities; and
''(F) representatives from among patient advocate
groups, health care professionals, persons living with
HIV/AIDS, and non-governmental organizations with
expertise relating to the prevention of mother-to-child
transmission activities, giving priority to individuals
in foreign countries in which programs under this Act
are administered.
''(3) Duties of panel.--The Panel shall--
''(A) review activities receiving financial
assistance under this Act to prevent mother-to-child
transmission of HIV and assess the effectiveness of
current activities in reaching the target described in
subsection (b)(1);
''(B) review scientific evidence related to the
provision of mother-to-child transmission prevention
services, including programmatic data and data from
clinical trials;
''(C) review and assess ways in which the Office of
the United States Global AIDS Coordinator and programs
funded under this Act collaborate with international
and multilateral entities on efforts to prevent mother-
to-child transmission of HIV in affected countries;
''(D) identify barriers and challenges to
increasing access to mother-to-child transmission
prevention services and evaluate potential mechanisms
to alleviate those barriers and challenges;
''(E) identify the extent to which stigma has
hindered pregnant women from obtaining HIV counseling
and testing or returning for results, and provide
recommendations to address such stigma and its effects;
''(F) identify opportunities to improve linkages
between mother-to-child transmission prevention
services and care and treatment programs;
''(G) evaluate the adequacy of financial assistance
provided under this Act for mother-to-child
transmission of HIV prevention services; and
''(H) recommend levels of financial assistance and
specific activities to facilitate reaching the target
described in subsection (b)(1).
''(4) Report.--
''(A) In general.--Not later than 14 months after
the date of the enactment of this Act, the Panel shall
submit a report containing a detailed statement of the
recommendations, findings, and conclusions of the Panel
to the appropriate congressional committees.
''(B) Availability.--The report submitted under
subparagraph (A) shall be made available to the public.
''(C) Consideration by coordinator.--The
Coordinator shall--
''(i) consider any recommendations
contained in the report submitted under
subparagraph (A); and
''(ii) include in the annual report
required under section 104A(e) of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b-2(e)) a
description of the activities conducted in
response to the recommendations made by the
Panel and an explanation of any recommendations
not implemented at the time of the report.
''(5) Authorization of appropriations.--There are
authorized to be appropriated to the Panel such sums as may be
necessary for each of the fiscal years 2009 through 2011 to
carry out this section.
''(6) Termination.--The Panel shall terminate on the date
that is 60 days after the date on which the Panel submits the
report to Congress under paragraph (4).''.
(c) Annual Report Elements.--Section 313(b)(2) of the United States
Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22
U.S.C. 7653(b)(2)) is amended--
(1) in subparagraph (C), by striking ''and'' at the end;
(2) in subparagraph (D), by striking the period at the end
and inserting a semicolon; and
(3) by adding at the end the following:
''(E) coordination and collaboration with
governments, donors, the private sector,
nongovernmental organizations, and other key
stakeholders to achieve the target described in section
312(b)(1); and
''(F) the number of women offered and receiving the
4 components of a comprehensive strategy to prevent
mother-to-child transmission of HIV, as recommended by
the World Health Organization.''.
Answer:
Global Pediatric HIV/AIDS Prevention and Treatment Act - States that the U.S. government's response to the global HIV/AIDS pandemic should place high priority on: (1) prevention of mother-to-child transmission of HIV/AIDS; and (2) care and treatment of all children affected by HIV/AIDS, including children orphaned by AIDS.

Requires that the global strategy under the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003: (1) establish a target for prevention of mother-to-child transmission efforts; (2) integrate prevention, care, and treatment with prevention of mother-to-child transmission programs; and (3) expand programs for children orphaned by AIDS.

Directs the Coordinator of United States Government Activities to Combat HIV/AIDS Globally to establish the Prevention of Mother to Child Transmission Panel which shall: (1) review activities to prevent mother-to-child transmission of HIV that receive financial assistance under this Act; and (2) provide recommendations to the Coordinator and to the appropriate congressional committees for of mother-to-child transmission prevention services under this Act.

Terminates the Panel 60 days after submission of a report required by this Act.